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Abstract
Background: The prevalence of Metabolic Syndrome and related chronic diseases, among them non-insulin-
dependent (type 2) diabetes mellitus, are on the rise in the United States and throughout the world. Animal models 
that respond to environmental stressors, such as diet, are useful for investigating the outcome and development of 
these related diseases.
Objective: Within this context, growth and energy relationships were characterized in the Nile rat, an exotic African 
rodent, as a potential animal model for diet-induced type 2 diabetes mellitus and Metabolic Syndrome.
Methods: Compiled data from several studies established the relationship between age, body weight gain (including 
abdominal adiposity), food and water consumption, and blood glucose levels as determinants of diabetes in male and 
female Nile rats. Glucose Tolerance Testing, insulin, HbA1c, blood pressure measurements and plasma lipids further 
characterized the diabetes in relation to criteria of the Metabolic Syndrome, while diet modification with high-fat, low-
fiber or food restriction attempted to modulate the disease.
Results: The Nile rat fed lab chow demonstrates signs of the Metabolic Syndrome that evolve into diet-induced non-
insulin-dependent (type 2) diabetes mellitus characterized by hyperinsulinemia with rising blood glucose (insulin 
resistance), abdominal adiposity, and impaired glucose clearance that precedes increased food and water intake, as 
well as elevated HbA1c, marked elevation in plasma triglycerides and cholesterol, microalbuminuria, and hypertension. 
Males are more prone than females with rapid progression to diabetes depending on the challenge diet. In males 
diabetes segregated into early-onset and late-onset groups, the former related to more rapid growth and greater 
growth efficiency for the calories consumed. Interestingly, no correlation was found between blood glucose and body 
mass index (overall adiposity) in older male Nile rats in long term studies, whereas blood glucose and the perirenal fat 
pad, as well as liver and kidney weight, were positively related to early-onset diabetes. Rats weaned early (4-5 wks) and 
challenged with a high-fat Western-type diet developed diabetes faster, and body fat accumulation was more 
apparent, whereas food restriction curtailed it.
Conclusion: The Nile rat fed typical rodent diets develops hyperinsulinemia that precedes hyperglycemia (insulin 
resistance) leading to diet-induced type 2 diabetes associated with hypertriglyceridemia, hypercholesterolemia, and 
hypertension. Dietary modulation affected growth rate (weight gain and central adiposity) to impact disease 
progression. This rodent model represents a novel system of gene-diet interactions affecting energy utilization that can 
provide insight into the prevention and treatment of the type 2 diabetes and Metabolic Syndrome.
Background
The Nile rat, aka the African grass rat (Arvicanthis niloti-
cus), is gerbil-like and native to the Nile River delta and
across most of sub-Saharan Africa where it lives in under-
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ground burrows and feeds mainly on vegetative plants
and grass seeds [1]. It was imported to the US in 1990s to
establish breeding colonies as a diurnal model for studies
of sleep and circadian rhythm [2]. However, such studies
are often complicated by diabetes that develops slowly in
many animals within the first months of life.
The Sand rat (Psammomys obesus) is a similar gerbil-
like rodent native to North Africa and the Near East that
has been investigated for energy-dependent diabetes and
serves as a valuable comparison [3-6]. It has a similar
background of food scarcity in its natural habitat; but
when fed a laboratory chow diet in captivity, it experi-
ences rapid onset of diabetes, a disease that has not been
observed among sand rats or Nile rats in the wild. Two
lines of sand rats have been bred by selection, one diabe-
tes-prone and one somewhat diabetes-resistant, with the
former demonstrating greater conversion of diet energy
efficiency into body weight gain than the latter [3].
With growing concern over the worldwide epidemic in
diabetes [7], the African grass rat was examined as a
potential model of type 2 diabetes that might allow more
detailed nutritional studies of a diet-induced diabetes
s i m i l a r  t o  t h a t  i n  h u m a n s .  S i n c e  t y p e  2  d i a b e t e s  i n
h u m a n s  i s  a s s o c i a t e d  w i t h  s e v e r a l  p a r a m e t e r s  t h a t  a r e
referred to as the Metabolic Syndrome and the Insulin
Resistance Syndrome [8,9], these parameters became the
focus of our studies. This report provides the first details
concerning various aspects of husbandry, energy require-
ments, as well as the potential for nutritional and age-
related modulation of the disease.
Methods
Breeding and weaning
In May 2005 six breeding pairs of Nile rats were obtained
from Michigan State University (courtesy of Dr. Laura
Smale, Psychology Dept, who initially encountered the
diabetes). These breeding pairs were maintained at Bran-
deis University in air-conditioned rooms with a 12 h light
cycle (temperature 68-72F, humidity 40-60%). All breed-
ers were fed ad libitum a typical laboratory chow (Lab
Diet #5008, 3.3 kcal/g, PMI Nutrition International,
Brentwood, MO) and water. Sixty-four breeding pairs
were added over the next 4 years, with selected rats eval-
uated for diabetes from different experiments and from
miscellaneous groups not on nutritional study. Approxi-
mately 1100 pups were weaned at 3 and 12 weeks of age
over this period and fed a second laboratory chow (Lab
Diet #5020, 3.6 kcal/g) ad libitum with water. At different
ages rats were assessed for random (nonfasting during
the day) or fasting blood glucose after overnight 16-hour
f o o d  r e s t r i c t i o n .  T h e y  w e r e  t h e n  p l a c e d  i n  i n d i v i d u a l
cages and evaluated further. All experiments were
approved by the Brandeis IACUC for experimentation
with animals.
Handling
Nile rats are alert, nervous and somewhat skittish rodents
that quickly dash into their 2" PVC tubing when alarmed.
Social animals living in burrows in their natural habitat,
the Nile rats thrives in the comfort of parents and/or sib-
lings. Isolation in individual cages may contribute to its
slightly aggressive nature, although this dissipates with
time and handling. Chewing of tails and ears occurs occa-
sionally in grouped rats, which can make tail bleeds diffi-
cult if scaring occurs. Barbering has been observed in
individuals, but especially when housed in groups, and
can be either focal or diffuse in nature. Gregarious, defen-
sive and biting when handled, capture of the Nile rat is
readily accomplished by gloved hand. Gently transferring
rats from cage to cage is achieved with rats hiding in their
PVC tubes, or by grasping tails, either with gloved hand
or using long forceps with tips covered by rubber tubing.
When threatened or frightened, young rats may try to
escape when handled.
Body weight
Weight was measured either with a rat in its PVC tube
(that had been previously tared) or when under light
anesthesia using a 50-50 oxygen and carbon dioxide gas
mixture funneled into the tube.
Body Mass Index (BMI) and Lean Mass Index (LMI)
The BMI and LMI for Nile rats were measured to deter-
mine whether body mass affected diabetic status. BMI
was calculated by dividing the body weight in kilograms
by the length (head to base of tail) in meters squared. LMI
was calculated the same way, except the carcass weight
(after all organs, brain, and fat depots were removed) was
used instead of the body weight.
Blood glucose
Fasted rats were deprived of food and given only water
for 16 h overnight, while random blood glucose was mea-
sured in non-fasted animals during the day (usually
between 11 am and 3 pm). To minimize handling and
excitement, rats were anesthetized when quietly hiding in
their PVC tubes by directing a 50-50 mixture of O2+CO2
into the tube for 15-30 seconds. Blood glucose was then
measured from tail blood using an Elite XL glucometer
(Bayer Co., Elhart, IN). The rat was returned to its cage to
awaken within 1 min.
Plasma triglycerides and total cholesterol
Blood samples were collected from the tail (30-70 μl) or
by cardiac puncture (100-200 μl with 30# needle) under
O2/CO2 anesthesia and placed in plastic vials moistened
with EDTA. Plasma triglycerides (TG) and total choles-
terol (TC) were determined spectrophotometrically using
Infinity™ kits (Thermo Fisher Scientific Inc., Middletown,
VA, TG ref # TR22421, TC ref # TR13421).Chaabo et al. Nutrition & Metabolism 2010, 7:29
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Liver lipids
Liver lipids (TG and TC) were extracted from 0.1 g of tis-
sue ground with 4 g of sodium sulfate using a 2:1 chloro-
form:methanol solution. Total extract was combined and
dried under nitrogen and redissolved in 1 ml of chloro-
form. An aliquot (10-20 μl) of each sample was dried
under nitrogen and dissolved in 50 μl of Triton X-100 and
c h l o r o f o r m  ( 1 : 1  b y  v o l u m e ) .  T h e  s o l u t i o n  w a s  d r i e d
extensively to remove chloroform, and TG and TC deter-
mined using the appropriate Infinity™ kit.
IpGlucose Tolerance Test (ipGTT)
Rats were fasted 16 h (overnight) and injected intraperi-
toneally with a glucose solution in saline at 2.5 g/kg body
weight. Blood glucose was measured from tail bleeds
before glucose injection (0 time) and after 1, 3 and 5 h
using an Elite XL glucometer.
Hemoglobin A1c (HbA1c)
The animals were deeply anesthetized with 50%/50% O2/
CO2, and blood was collected by cardiac puncture using
EDTA-wetted insulin syringes. Glycated hemoglobin
(GHb) was measured by GLYCO-Tek affinity column kit
(Helena Laboratories, Beaumont, Texas). HbA1c was cal-
culated using the equation provided by the company.
Insulin Enzyme-Linked Immunosorbent Assay for Insulin 
(ELISA)
Plasma insulin was determined with an enzyme-linked
immunosorbent assay (ELISA) kit for rat/mouse insulin
(Linco Research, Millepore, Billerica, MA, catnr. EZRMI-
13K), according to the manufacturers' protocols.
Males vs females (Expt 1)
To examine sex differences in diabetic response, a group
of 13 males and 10 females was fed lab chow #5020 ad
libitum with water in groups of four animals after wean-
ing at 5 wks until housed separately from 11 wks to 44
w k s .  D a i l y  f o o d  a n d  w a t e r  i n t a k e  w e r e  r e c o r d e d ,  a n d
body weight gain and random blood glucose were mea-
sured at different time points.
Blood glucose determinants (Expt 2)
For an overview on the relationship between growth and
diabetes progression, glucose was assessed in a larger
pool of approximately 100 male and 60 female individu-
ally housed Nile rats fed lab chow #5020 and water ad
libitum weaned at the age between 6 and 12 wks by mea-
suring both random or fasting tail bloods in cross-sec-
tions of rats up to 36 wk of age.
Early-onset, late-onset study (Expt 3)
To describe individual Nile rat growth dynamics and dia-
betes onset in detail, 11 male eight-wk old rats were fed a
high-fat, low-fiber Western-type purified diet
(CHO:Fat:Protein, energy ratio of 40:43:17, 4.5 kcal/g,
Table 1, Hayes-Cathcart vitamin mix [10]) for 24 wks.
After the initial 12 wks on diet, rats were categorized as
either early-onset (n = 6), or late-onset diabetic (n = 5)
based on a random blood glucose >150 mg/dl or <150
mg/dl, respectively. Parameters continued to be moni-
tored until 32 wk of age.
Body fat and diabetes (Expt 4)
In order to elucidate the relation of body fat pools to
stages of diabetes, 20 male rats were fed lab chow #5020
and followed individually from separation at 12 wks to 7
mo (10 rats) or 11 mo of age (10 rats). Random blood glu-
cose was measured at 7 or 11 mo. Fasting terminal blood
glucose and plasma lipids, as well as organ weights
(including fat pads), were assessed.
Insulin resistance and diabetes categories (Expt 5)
To map diabetes onset and progression from an early age,
83 male Nile rats were weaned (separated) and chal-
lenged with the W estern-type diet (T able 1). Rats were
weaned (separated from parents) at either 4-5 wks (fed
Western-type diet for 2 wks), or at 6-7 wks (fed Western-
type diet for 4 wks), or at 8-9 wks (fed Western-type diet
for 12 wks) in order to establish different windows for
evaluation of diabetes. Insulin concentration, random
blood glucose, body weight and plasma lipids were ana-
lyzed when sacrificed after 2, 4, or 12 wks of challenge.
The rats were then categorized according the progression
of the disease in four stages classified as A, B, C and D
[11]. Stage A was characterized by low plasma insulin
(<3.5 ng/ml) and low random blood glucose (<150 mg/
dl); stage B (hyperinsulinemia) by elevated insulin (>3.5
ng/ml) and low random blood glucose (<150 mg/dl);
stage C (diabetes) by both elevated insulin (>3.5 ng/ml)
and random blood glucose (>150 mg/dl); while stage D
(beta-cell failure) represented declining insulin (<3.5 ng/
ml) and elevated random blood glucose (>150 mg/dl).
Collectively they reflected stages of diabetes from insulin
resistance to hyperglycemia, followed eventually by beta-
cell failure and insulin depletion. Stage E is characterized
by return to low insulin (<3.5 ng/ml) and low random
blood glucose (<150 mg/dl) observed in the end stage of
the disease (ie. after having passed through all earlier
stages and they cease to eat). None of the animals ana-
lyzed in these experiments reached this stage, which is
encountered only rarely.
Early weaning effect on diabetic categories (Expt 6)
To further assess diabetes categories and organ changes
following early weaning, 8 male Nile rats were monitored
closely after weaning at 5 wks, while fed our high-fat,
low-fiber Western-type diet (Table 1). After 4 wks of diet
challenge, the 8 rats were killed, and subsequently catego-
rized into two groups of 4 (early-onset and late-onset dia-Chaabo et al. Nutrition & Metabolism 2010, 7:29
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betes) based on their random blood glucose, plasma
lipids, insulin, and HbA1c. Food and water intake, as well
as body weight were monitored.
Effect of high-fat versus low-fat diets (Expt 7)
To examine possible dietary impact on diabetes, rats were
challenged with the Western-type diet or a low-fat, high-
fiber Mediterranean-type diet (Table 1) to assess the
impact on progression of diabetes. Twelve 5-wk old males
were divided into three groups of 4 and fed for 24 wks
either of these two purified diets or a lab chow (ProLab,
RMH #3000, energy ratio 60:14:26, 3.2 kcal/g). Food and
water consumption was measured twice weekly for 24
wks. Body weight and tail random blood glucose were
measured at the beginning of the experiment and after 24
wks. The rats were anesthetized, and final fasting blood
glucose was measured before exsanguination. The inter-
nal organs and different fat pads were collected and
weighed, and plasma as well as liver were analyzed for TG
and TC. Additionally, at about one week before termina-
tion an intraperitoneal glucose tolerance test (ipGTT)
Table 1: Composition of purified diets1
INGREDIENTS Diet
Mediterranean-type Western-type
(Low-fat/high-fiber) (High-fat/low-fiber)
CHO:Fat:Prot %en 69:15:16 40:43:17
kcal/g 3.5 4.5
g/Kg
Casein 20 80
Lactalbumin 20 80
Oatmeal (7.5%fat) 733 200
Wheatbran (4.25% fat) 70 0
Dextrose 0 170
Cornstarch 60 170
Cellulose 44 31
(Total fiber)2 (147) (51)
Fat (Sats:Monos:Polys) (3:5:7) (19:18:6)
Milk fat (chol stripped) 42
Tallow (chol stripped) 97
Lard 31
Soybean oil 30
(Total fat)2 (58) (15)
Mineral mix (Ausman - Hayes)3 40 52
Vitamin mix (Hayes - Cathcart)4 11 14
Choline chloride 2 3
1 Diets which were prepared in the lab were fed to Nile rats as cake, prepared by with holding from the formulation 60 g/kg cornstarch 
premixed into 800 mL of simmering water before addition to the remaining ingredients
2Includes fiber or fat in oatmeal and wheatbran
3Ausman-Hayes mineral mix # 210077, Diets, Inc., Bethlehem, PA
4 Hayes-Cathcart vitamin mixChaabo et al. Nutrition & Metabolism 2010, 7:29
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was conducted to evaluate the effect of caloric density on
the development of diabetes.
Calorie restriction study (Expt 8)
A food restriction study was conducted to determine its
effect on diabetes. Eleven 20-wk old Nile rats (6 males
a n d  5  f e m a l e s )  w e r e  a s s i g n e d  t o  2  g r o u p s  w i t h  a m p l e
access to water and fed lab chow #5020 or chow restricted
to 75% of ad libitum for another 18 wks. Body weight and
blood glucose were measured at the beginning, mid-point
and end point of the study. An ipGTT was assessed by tail
bleeds, followed by terminal exsanguination under anes-
thesia to collect plasma for additional measures. Internal
organs and selected fat pads were excised and weighed.
Blood pressure (Expt 9)
To evaluate blood pressure, 13 male 8-wk old Nile rats
were weaned to lab chow (Lab Diet, #5020). Blood pres-
sure was measured 4 times between 27 wk to 43 wk of age
using an all-cuff noninvasive IITC Life Science manual
inflation amplifier Model 29 (NIBP Amplifier, Woodland
Hills, CA. 91367).
To calibrate the cuff the temperature chamber was set
to 32°C and the cuff and cables placed inside. The rat was
briefly anesthetized with 50%/50% O2/CO2 to place it
without struggle in the restrainer inside the temperature
chamber. A plastic collar (1 cm × 0.5 cm) was fitted inside
the cuff to better adapt the tail diameter to sensor diame-
ter. Preliminary tests revealed the effectiveness of this
modification with improved signal recordings. Once the
measurements stabilized, the cuff was inflated to 100
mmHg, then 150 mmHg or more to assure correct read-
ings. Measurements were repeated 3-5 times and the
average of this values was taken. Growth dynamics and
fasting blood glucose were also examined. After the initial
14 wks on lab chow (Lab Diet, #5020), the 13 rats were
categorized with either early-onset (n = 3), or late-onset
diabetes (n = 10) based on a fasting blood glucose >110
mg/dl or <110 mg/dl, respectively. At the age of 43 wks
the animals were exsanguinated from the heart to assess
their lipid and insulin profiles.
Growth efficiency
By measuring daily food intake and body weight gain over
a set period of growth, it was possible to calculate growth
efficiency as the number of calories needed per gram of
body weight gain. Thus, the highest growth efficiency
represented the fewest calories consumed per weight
gained.
Statistical analysis
Statistical analysis was performed using the Super
ANOVA statistical software (Abacus Concepts. Inc,
Berkeley, CA). Corrected Students T-test for unequal
variances (p < 0.05), or one-way ANOVA with a posthoc
Fischer's PLSD test (p < 0.05), were conducted where
appropriate to study design. Z-test was used for correla-
tions.
Results
General colony dynamics, Expts 1 and 2
Nile rat growth (Expt 1)
Figure 1 depicts the growth rate, energy intake, water
intake, and random blood glucose in 23 rats (13 males
and 10 females) that had been housed in groups of 4 until
the start of the study at 11 wks, when they were housed
individually. In general, the average weight of 8-wk old
weanlings is about 50 g for females and 60 g for males.
These 23 rats were monitored at monthly intervals for 8
mo, ie. between 11 and 44 wks of age. Males grew faster,
gaining 80% of their total weight between 11-20 wks,
while females gained only 40% of their final weight in that
period. Males reached a final body weight of approxi-
mately 130 g at 40 wks, while females finally weighed
about 110 g. In general, Nile rats that survive beyond 1
year eventually die due to consequences of hyperglyce-
mia, hyperlipidemia with high triglycerides, elevated cho-
lesterol and hypertension. Elevated VLDL and LDL with
depressed HDL (unpublished data) and renal dysfunction
with microalbuminuria along with cataracts and other
complications associated with progressive diabetes were
also observed (data not shown).
Energy and water intake
Figure 1B displays the energy intake of the same 23 Nile
rats. While females only increased caloric intake slightly
over time, males increased food intake substantially after
27 wks following diabetes onset. Food intake was greater
for males than females at every time point. A t 39 wks
males (mostly diabetic by now) averaged 64 kcal/d com-
pared to 32 kcal/d for females (mostly nondiabetic). Fig-
ure 1C indicates that water consumption increased in
males as food intake (and blood glucose) increased. Nor-
mal females drank about 10 ml/d, while normal males
drank about 15 ml/d. Male Nile rats with fasting blood
glucose over 350 mg/dl drank as much as 70 ml/day.
Random blood glucose
Random blood glucose was measured at 23, 39 and 44 wk
of age in these same rats (Figure. 1D). Males had higher
blood glucose at all time points, almost tripling between
23 wks and 39 wks from 137 mg/dl to 336 mg/dl. In
females glucose only doubled from 56 mg/dl to 101 mg/dl
during the same 16 wk interval. At 44 wk random glucose
in male rats had increased slightly to 368 mg/dl, while
females had increased substantially to 151 mg/dl.
Blood glucose determinants (Expt 2)
Fasting and random blood glucose were measured in var-
ious experiments to determine the progression of diabe-
tes in typical rats fed chow (Figure. 2A,B). Both valuesChaabo et al. Nutrition & Metabolism 2010, 7:29
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increased with age in both sexes, with males exceeding
females at all time points. Both random and fasting blood
glucose typically averaged between 40-60 mg/dl for 4-6-
wk old Nile rats of either gender, with the lower values
associated with the youngest rats. Random blood glucose
initially increased as early as 10 wks in some males, with
fasting values following suit; and males diverged consid-
erably from females as they aged. The increase in males
was typically steady and dramatic by 24-36 wks, with ran-
dom values averaging about 240 mg/dl for males and 140
mg/dl for females in that time period. In rats surviving
beyond one year, weight loss was commonly observed as
diabetes progressed, often associated with decreased
food and water intake at the end stage of the disease (data
not shown).
Individual blood glucose (diabetes) dynamics (Expt 3)
The wide variation in growth observed among male Nile
rats in preliminary studies raised the question whether
growth rate per se influenced diabetes onset. Thus, in
experiment 3 the random  blood glucose in a typical
cohort of 11 male Nile rats was measured monthly
Figure 1 (Expt 1). Nile rat growth dynamics for 13 males and 10 females fed lab chow (Lab Diet, #5020). Body weight change (A), energy (B) and water 
intake (C) and random blood glucose (D) in male and female Nile rats were measured periodically (mean ± SEM) between 11 and 44 wk of age.
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between 8 and 32 wk of age, comparing glucose to growth
rate as well as growth efficiency based on energy intake
(Figure. 3). Two distinct growth patterns were associated
with blood glucose. At 24 wk of age an early-onset dia-
betic group (random glucose >150 mg/dl, n = 6) was
observed to have more rapid growth. This subset was ret-
rospectively found to have elevated glucose at 20 wk of
age, which was already significantly higher than the late-
onset group (n = 5). Blood glucose remained normal in
the latter group until 24 wks, whereupon it began to rise
to finally approximate that of the early-onset group by the
end of study at 32 wks (Figure. 3A). In other words, diabe-
tes was delayed about 10-12 wks in the late-onset group.
Body weight data revealed that the early-onset group
gained 75% (to 115 g) of final weight by 16 wks (Figure.
3B), when random blood glucose began to increase (Fig-
ure. 3A). By contrast, the late-onset group gained signifi-
cantly less at only 44% (to 92 g) by 16 wks. At 24 wks the
early-onset group had reached 98% final weight (128 g)
with an elevated random blood glucose (263 mg/dl),
whereas the late-onset group was at 84% final weight (114
g) and 61 mg/dl, respectively. In fact, during weeks 8-12
the early-onset group gained twice the weight of late-
onset rats, while consuming equal calories (Table S1,
Additional file 1). Thus, growth efficiency (per calorie
consumed) in this period was double that of early-onset
rats (p < 0.05), even though blood glucose was still low
and identical between groups. However, by 16-20 wks
when weight gain slowed in early-onset rats, their blood
glucose had tripled. On the other hand, the blood glucose
rose about 10-12 wks later in the late-onset group, after
their weight gain accelerated and body weight had
increased and plateaued. The enhanced growth efficiency
of early-onset rats disappeared by the end of study, when
both groups were equally diabetic and weight gain
(growth) had stabilized at nearly equal body weights.
Since growth was essentially over, food energy reflected
weight maintenance and ceased to be relevant for esti-
mating growth efficiency (Figure. 3E). Differences were
more pronounced for water intake (Figure. 3C,D).
To assess diabetic status in relation to critical organ
weights and blood lipids, random or fasting blood glucose
were compared to liver and kidney weights, as well as
fasting plasma triglycerides and total cholesterol at the
end of the study (Figure. 4). The strongest correlation
existed between either fasting (r = 0.91) (data not shown),
or random (r = 0.84) blood glucose and liver weight, and
to a lesser extent with kidney weight (r = 0.64), but total
adipose mass was unrelated to blood glucose (Figure.
4A,B,C). Total fasting plasma cholesterol (r = 0.77) and
triglycerides (r = 0.74) were equally well-correlated with
random blood glucose (Figure. 4D,E), which was slightly
better than correlations with fasting blood glucose (data
not shown).
Figure 2 (Expt 2). Blood glucose distribution is depicted for a cross-section of male and female Nile rats fed chow (#5020). Random blood glucose 
(A) or fasting blood glucose (B) was measured at different ages (6-36 wks). Observations, n, varied at each time period. Values are mean ± SEM. *Sig-
nificantly different (P < 0.05).Chaabo et al. Nutrition & Metabolism 2010, 7:29
http://www.nutritionandmetabolism.com/content/7/1/29
Page 8 of 21
Body fat and diabetes onset (Expt 4)
Results in Table 2 further explore the relationships
between diabetes onset, organ weights (including fat
pads), and plasma lipids in a long-term experiment. The
first 10 rats killed at 7 mo divided equally into diabetic (n
= 5) or nondiabetic (n = 5) groups based on random
blood glucose >150 mg/dl, similar to the pattern seen in
Expt 2. Although food and water intake were not mea-
sured in the 7 mo rats, body weight was significantly
greater in the 5 rats that had developed diabetes. After 16
h fasting, blood glucose was 50% higher in diabetics, but
was not significant due to variation. Their livers were sig-
nificantly enlarged at necropsy, while kidneys tended to
be larger. Total adipose accumulation was similar
between diabetics and nondiabetics. Both total choles-
terol and triglycerides tended to be increased in this
early-onset group (Table S1, Additional file 1, 7 mo).
By contrast, only 3 of the 10 rats killed after 11 mo were
still nondiabetic based on random and fasting glucose,
whereas 7 were diabetic. Body weights were now similar,
but liver and kidneys in the diabetic rats were double the
size of those in nondiabetics; and now the perirenal adi-
pose pool was significantly reduced in diabetics, while
blood lipids were extremely elevated, especially triglycer-
ides in individual rats (Table 2).
Insulin resistance and early progression (Expt 5)
Table 3 details the relationships between body weight,
fasting insulin, and plasma lipids, expressed in terms of
diabetes stages that developed after different ages at
weaning (separation) age and progressively longer expo-
sure to diet challenge. For this experiment, 36 male Nile
rats were weaned when 4-5 wks old and followed for 2
wks; a second group of 27 males were separated at 6-7
wks and followed for 4 wks; while a third group of 20 was
separated at 8-9 wks and followed 12 wks. All were
housed individually and fed the high-fat, low-fiber West-
ern-type diet (Table 1). The question was how early and
what degree of diabetes could be detected following a
challenge diet? Within each of the three age groups, four
stages of diabetes were identified (Table 3). Stage A repre-
sented low insulin (<3.5 ng/ml) and low random blood
glucose (<150 mg/dl). Development of insulin resistance
(stage B) was defined by elevated insulin (>3.5 ng/ml) and
low random blood glucose (<150 mg/dl). Stage C
(entrenched diabetes) was characterized by both elevated
insulin (>3.5 ng/ml) and random blood glucose (>150
mg/dl); Stage D represented depressed insulin, while
blood glucose and lipids were still elevated (beta-cell fail-
ure). The latter was only achieved in the oldest rats (fol-
lowed for the longest time).
Figure 3 (Expt 3). Dynamics of random blood glucose, body weight, food and water intake and energy efficiency for two groups of male Nile rats 
with early or late onset to diabetes. Eleven 8 wk-old male Nile rats were fed Western-type diet for 24 wks and categorized as either early-onset (n = 6) 
or late-onset (n = 5) based on random blood glucose. Random blood glucose (A), body weight (B), caloric intake (C), water intake (D) and growth ef-
ficiency (E) were measured monthly for both onset groups over a period of 6 mo. Note that weight gain preceded glucose elevation, especially in the 
early-onset group. Values are mean± SEM. *Significantly different (p < 0.05).Chaabo et al. Nutrition & Metabolism 2010, 7:29
http://www.nutritionandmetabolism.com/content/7/1/29
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Already by 6-10 wk of age, and 2-4 wks of challenge
diet, more than 60% of these male rats had progressed
beyond Stage A. By 20 wks of age and 12 wks of diet, 85%
had moved beyond Stage A. Between 7 wks and 20 wks of
age the number of rats in Stage C had essentially tripled
and a small percentage (15%) now showed in Stage D.
Insulin typically increased about 7-fold by Stage B (in
approximately 50% of the younger rats), and peaked
slightly above this level at 16-20 wks, before declining
into Stage D. The rise in blood glucose, a delayed rise in
TG, paralleled insulin dynamics, except glucose contin-
ued to increase when insulin declined in Stage D. An
increase in TC was less dramatic. In general, for all three
age groups, rats that had progressed to stages B and C, (or
stage D for the oldest rats), were those that gained signifi-
cantly more weight than those still in stage A, ie. they
grew at a faster rate.
Early vs. late diabetes in young rats (Expt 6)
Based on the trend in experiment 5, we determined
whether young rats would rapidly separate into early-
onset and late-onset diabetes based on growth efficiency
and calorie intake. Accordingly, 8 male Nile rats were
weaned at 5 wks and fed the high-fat, low-fiber Western-
type diet for 4 wks. When sacrificed, they were catego-
rized as early- or late-onset diabetes based on their
weekly random blood glucose history (Table 4). Similar to
rats weaned and killed at older ages (Expt 3 and 4), the
early-onset group had gained significantly more weight
(14%) than late-onset rats after only 2 wks on diet, which
was still apparent after 4 wks when sacrificed. Interest-
ingly the early-onset rats revealed greater skeletal length
(6%), relatively less carcass mass, more adipose than the
late-onset rats. This was related to greater food and water
intake measured during the first 2 wks in the early-onset
Figure 4 (Expt 3). Correlations between random blood glucose and liver, kidney, adipose weight (expressed as %BW) and plasma lipids for 11 male 
Nile rats. Correlation between blood glucose and liver (A), and kidney (B), and total adipose (C), and TG (D), and TC (E). The slightly inverse trend for 
adipose likely reflects the probability that fat disappears as diabetes advances.Chaabo et al. Nutrition & Metabolism 2010, 7:29
http://www.nutritionandmetabolism.com/content/7/1/29
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group, but was more strikingly linked to the 2 wk growth
efficiency (18 kcal/g BW gain) which was significantly
better (33%) than the late-onset group during that inter-
val (28 kcal/g BW gain). The terminal random blood glu-
cose after 4 wks also differed at 344 mg/dl compared to
46 mg/dl, respectively. Unlike longer experiments, nei-
ther liver nor kidneys were enlarged, but triglycerides,
insulin and HbA1c were significantly elevated in the dia-
betic rats (Table 4). However, neither BMI nor LMI were
affected by diabetic status, suggesting that neither the rel-
ative overall fat mass nor carcass mass (muscle/bone)
were appreciably altered from a total body perspective.
Glucose response to high-fat versus low-fat diets (Expt 7)
In order to explore the effect of dietary fat and fiber on
Nile rat diabetes, purified diets were compared to chow
Table 2: Body and organ weights, random blood glucose and plasma lipids for 7 and 11 mo old male Nile rats fed chow 
(#5020) with different onset to diabetes (Expt 4)
7 mo 11 mo
Non-diabetic Diabetic Non-diabetic Diabetic
R. blood gluc <150 
mg/dL
R. blood gluc >150 
mg/dL
R. blood gluc <150 
mg/dL
R. blood gluc >150 
mg/dL
n = 5 n = 5 n = 3 n = 7
Body weight, 
terminal (g)
112 ± 7 127 ± 13* 126 ± 10 124 ± 13
Food intake last mo 
(kcal/d)
NA NA 37 ± 3 76 ± 15*
Water intake last mo 
(mL/d)
NA NA 10 ± 2 72+8*
Blood glucose (mg/dL)
Random 75 ± 43 266 ± 81* 98 ± 43 448 ± 39*†
15 h fasting 43 ± 15 67 ± 25 79 ± 64 210 ± 99†
Organ weight (%BW)
Liver 2.85 ± 0.32 4.35 ± 1.02* 2.66 ± 0.34 6.70 ± 0.62*†
Kidney 0.77 ± 0.15 1.00 ± 0.21 0.82 ± 0.13 1.37 ± 0.26*
Adipose
Perirenal 1.66 ± 0.66 2.28 ± 0.53 2.00 ± 0.91 0.68 ± 0.22*†
Epididymal 4.12 ± 0.71 2.88 ± 0.74 3.23 ± 0.70 2.53 ± 1.01
Suprascapula
r (brown fat)
1.90 ± 0.48 2.02 ± 0.37 1.97 ± 0.20 1.44 ± 0.73
Total fat 
(all 
above)
7.68 ± 1.31 7.18 ± 1.31 7.20 ± 1.61 4.64 ± 1.36†
Plasma
TC (mg/dL) 141 ± 21 173 ± 43 122 ± 26 391 ± 140*†
TG (mg/dL) 49 ± 16 124 ± 86 70 ± 16 659 ± 626
Values are mean ± SD, total n = 20, NA = not available
* Significant difference between non-diabetic and diabetic rats at 7 mo. (p < 0.05)
† Significant difference between 7 and 11 mo, (p < 0.05)Chaabo et al. Nutrition & Metabolism 2010, 7:29
http://www.nutritionandmetabolism.com/content/7/1/29
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in twelve 5 wk-old male rats (Table 5). The high-fat, low-
fiber diet (Western-type diet, 4.5 kcal/g), described above
was compared to a low-fat, high-fiber Mediterranean-
type diet, 3.5 kcal/g (Table 1) along with a third group fed
chow as control at 3.57 kcal/g. Although the high-fat,
low-fiber group consumed 20% less energy per day com-
pared to the low-fat, high-fiber group (n.s.) the weight
gain/d in the former was 10% greater after 20 wks (n.s.).
However, the total adipose pool did not differ between
the three groups at study end, and the cecum was largest
(n.s.) in the low-fat, high-fiber group. Initially, at 5 wks
the random blood glucose was similar for all groups ana-
lyzed, but after 24 wks the low-fat group had the lowest
Table 3: Crossectional comparison in male Nile rats separated between 4 and 9 wks and fed high-fat, low-fiber Western-
typediet for 2 to 12 wks to assess stages of insulin resistance (Expt 5)
Stages
ABCD
Age at separation
4-5 wks (followed for 2 
wks)
BW (g) 70 ± 11a,b 79 ± 9a 83 ± 13b
n = 36 13 (36%) 18 (50%) 5 (14%) 0
Insulin (ng/mL) 1.0 ± 0.8a,b 7.7 ± 3.1a 6.3 ± 1.7b
Random blood glucose 
(mg/dL)
72 ± 33a 77 ± 33b 223 ± 65a,b
TG (mg/dL) 53 ± 23a 69 ± 21b 145 ± 75a,b
TC (mg/dL) 91 ± 33 96 ± 19 105 ± 33
Age at separation
6-7 wks (followed for 4 
wks)
BW (g) 89 ± 10a,b 101 ± 11a 103 ± 12b
n = 27 11 (41%) 11 (41%) 5 (19%) 0
Insulin (ng/mL) 1.9 ± 1.1a 6.8 ± 2.2a 5.4 ± 3.8
Random blood glucose 
(mg/dL)
44 ± 12a 59 ± 25b 341 ± 154a,b
TG (mg/dL) 37 ± 10a 50 ± 21b 286 ± 129a,b
TC (mg/dL) 57 ± 11a 80 ± 15b 117 ± 72a,b
Age at separation
8-9 wks (followed for 
12 wks)
BW (g) 101 ± 14a,b 120 ± 7 126 ± 14a 133 ± 23b
n = 20 3 (15%) 6 (30%) 8 (40%) 3 (15%)
Insulin (ng/mL) 1.4 ± 0.4a,b 7.4 ± 2.1a,c 9.0 ± 4.3b,d 1.7 ± 0.9c,d
Random blood glucose 
(mg/dL)
62 ± 17a,b 70 ± 6c,d 340 ± 165a,c,e 534 ± 72b,d,e
TG (mg/dL) 55 ± 16a 66 ± 7b 192 ± 141a,b 132 ± 26
TC (mg/dL) 129 ± 16 111 ± 19 172 ± 108 176 ± 25
Values are mean ± SD
a,b,c,d,e Means in row sharing a common superscript are significantly different (P < 0.05) using one-way ANOVA and Fischer's PLSD test.
Stage A = normal, Stage B = elvevated insulin, Stage C = elevated insulin and glucose, Stage D = declining insulin, elevated glucoseChaabo et al. Nutrition & Metabolism 2010, 7:29
http://www.nutritionandmetabolism.com/content/7/1/29
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Table 4: Body and organ weights, blood glucose, fasting insulin and plasma lipids for 5-wk old male Nile rats with early- or 
late-onset diabetes when fed a high-fat, low-fiber purified diet for 4 wks (Expt 6)
High-fat, low-fiber diet (Western-type)
Early-onset Late-onset
Body weight (g)
Initial (age: 5 wks) 62 ± 6 61 ± 4
After 2 wks 90 ± 6 79 ± 7*
After 4 wks 104 ± 6 90 ± 8*
Body weight gain (wks 5-7) (g/d) 2.2 ± 0.1 1.3 ± 0.4*
Food Intake (wks 5-7) (g/d) 14.8 ± 0.6 12.3 ± 0.9*
(kcal/d) 40.5 ± 1.7 33.8 ± 2.8*
Growth efficiency (kcal/d/g BW gain) 18.5 ± 1.1 28.2 ± 7.1*
Water Intake (wks 5-7) (mL/d) 15 ± 6 9 ± 5
Random blood glucose (mg/dL)
Initial (age: 5 wks) 110 ± 55 79 ± 18
After 4 wk 344 ± 80 46 ± 10*
Organ weight (%BW)
Liver 3.87 ± 0.84 3.22 ± 0.42
Kidney 0.73 ± 0.11 0.70 ± 0.13
Adipose
Perirenal¥ 2.65 ± 0.33 1.82 ± 0.76*
Epididymal 5.40 ± 0.57 3.80 ± 0.98*
Omental 2.61 ± 0.38 2.05 ± 0.59
Inguinal 1.64 ± 0.20 1.39 ± 0.42
Suprascapular (brown fat) 2.18 ± 0.16 1.52 ± 0.49
Total fat (all above) 14.5 ± 1.5 10.6 ± 2.8*
Carcass 67.2 ± 0.9 72.8 ± 2.2*
Body length (cm) 13.4 ± 0.2 12.6 ± 0.5*
BMI (kg/m2)5 . 8  ±  0 . 4 5 . 5  ±  0 . 2
LMI (Carcass wt kg/m2)3 . 9  ±  0 . 2 4 . 0  ±  0 . 1
Plasma
TC (mg/dL) 88 ± 26 63 ± 4
TG (mg/dL) 126 ± 14 96 ± 19*
Insulin (ng/mL) 18.2 ± 3.4 5.3 ± 3.2*
HbA1c (%) 6.5 ± 0.7 5.3 ± 0.4*
Values are mean ± SD (n = 4)
* Significantly different (P < 0.05)
¥ Represents perirenal + retroperitoneal fat pad.Chaabo et al. Nutrition & Metabolism 2010, 7:29
http://www.nutritionandmetabolism.com/content/7/1/29
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Table 5: Food intake, body and organ weights, blood glucose and plasma lipids for 5-wk old male Nile rats fed 3 types of 
diets for 24 wks (Expt 7)
Diet:
#1 #2 (Western-type) Chow
Low-fat, high-fiber High-fat, low-fiber (RMH #3000)
CHO: FAT: Prot %en 69:15:16 40:43:17 60:14:26
Body weight (g)
Initial (5 wks old) 51 ± 3 52 ± 7 55 ± 5
Final (24 wk trial) 110 ± 11 118 ± 19 131 ± 9
Body weight gain (g/d) 0.34 ± 0.06 0.38 ± 0.09 0.41 ± 0.07
Food intake as dry diet (g/d) 22.5 ± 1.5 14.3 ± 1.0† N/A
(kcal/d) 79 ± 5 64 ± 4 N/A
Organ weight (%BW)
Liver 5.39 ± 0.54a 7.23 ± 1.06a,b 4.48 ± 1.41b
Kidney 1.26 ± 0.31 1.47 ± 0.33a 0.98 ± 9.30a
Cecum 3.3 ± 0.9 2.1 ± 1.0 2.1 ± 1.3
Adipose
Perirenal* 0.80 ± 0.59 0.73 ± 0.62 1.34 ± 0.53
Epididymal 2.25 ± 0.69a 2.59 ± 0.82 3.33 ± 0.35a
Inguinal 0.73 ± 0.42 0.72 ± 0.25 0.85 ± 0.15
Total (all above) 3.79 ± 1.62 4.04 ± 1.64 5.52 ± 0.98
Carcass 68 ± 3 68 ± 3 69 ± 4
Initial blood glucose (mg/dl) 61 ± 4 81 ± 13 N/A
Random, 24 wk glucose (mg/dl) 395 ± 149a 276 ± 82 150 ± 82a
Fasting, 24 wk glucoseÁ (mg/dl) 76 ± 17 158 ± 114 118 ± 142
Liver Lipids
TC (mg/g) 3 ± 1a 15 ± 3a,b 5 ± 2b
TG (mg/g) 18 ± 8a 137 ± 40a,b 35 ± 6b
Plasma (fasting, terminalÁ)
TC (mg/dL) 199 ± 51 568 ± 400a 97 ± 14a
TG (mg/dL) 194 ± 26a 1371 ± 992a,b 203 ± 78b
Values are Mean± SD (n = 4). NA = not available.
a,b,c.. Means in a row sharing a common superscript differ (p < 0.05) using one-way ANOVA and Fisher's PLSD test.
ÁBlood glucose after 16 h fasting. † Significantly different (p < 0.05).
*Perirenal represents the perirenal and retroperitoneal fat poolChaabo et al. Nutrition & Metabolism 2010, 7:29
http://www.nutritionandmetabolism.com/content/7/1/29
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fasting blood glucose, even though its random blood glu-
cose was highest (Table 5).
The ipGTT after 20 wks on diet (Figure. 5) indicates
that rats fed the high-fat, low-fiber diet had an elevated
baseline blood glucose (146 mg/dl) that peaked at 829
mg/dl after one hour. After 5 h it was still 345 mg/dl. The
chow group averaged the same blood glucose at baseline
(at 146 mg/dl), but only rose to 360 mg/dl by one hour
and 235 mg/dl after 5 h, still well above the initial value.
By contrast, the low-fat, high-fiber group had the lowest
0-time blood glucose at 76 mg/dl, which reached 342 mg/
dl at 1 h and returned to 96 mg/dl after 5 h.
After 24 wks, liver and kidney weights, liver TC, and
TG, as well as plasma TG were significantly greater in rats
fed the high-fat, low-fiber diet compared to chow (Table
5).
Calorie restriction studies (Expt 8)
Nile rats were fed either rat chow (#5020) ad libitum or
that diet restricted to 75% of ad libitum for 18 wks (Table
6). When ipGTT was assessed, the calorie-restricted rats
had an initial fasting blood glucose of 72 mg/dl, com-
pared to 211 mg/dl for rats fed ad libitum. At 1 h the ad
libitum group rose to 517 mg/dl, more than twice that of
the restricted group at 226 mg/dl. The only significant
difference in organ weights occurred in the liver, which
was larger by 20% (p < 0.05) in the ad libitum diabetic rats
c o m p a r e d  t o  t h e  r e s t r i c t e d  g r o u p .  E v e n  t h o u g h  b o d y
weight did not differ between groups, the fasting blood
glucose was significantly lower in the restricted group
after 13 wks (36 mg/dl versus 70 mg/dl), as well as termi-
nally (72 mg/dl versus 211 mg/dl) after 18 wks.
Blood pressure (Expt 9)
In order to follow blood pressure, 13 male Nile rats were
weaned to chow (Lab Diet, #5020) at the age of 8 wks and
assessed for blood pressure over 21 weeks, starting at 5
mo of age, ie. when these rats distributed into early-onset
or late-onset groups based on fasting blood glucose. Glu-
cose became elevated by 22 wks of age in 3 rats (early-
onset), while the remaining 10 began an equivalent rise
only when about 40 wks old. The blood pressure rise
lagged the blood glucose profile somewhat, becoming
elevated in the early-onset group when 34 wk old and
increasing or remaining elevated thereafter. BP increased
in late-onset rats at 43 wks and then approximated the
early-onset group. Urinalysis conducted in the early-
onset rats revealed polydipsia and polyuria with typical
signs of kidney failure, including microalbuminuria and
hyperglucosuria, sometimes even ketones (data not
shown). No difference in body weight was observed over
the comparison period, even though the early-onset
group started to loose weight slightly after 27 wks of age,
indicating late-stage diabetes.
Marked elevations in fasting glusose and plasma lipids
in the early-onset group at study end indicated that their
diabetes was, indeed, more advanced, and that they had
proceeded to stage D where the plasma insulin was
depleted as result of beta-cell failure (Table 7).
Discussion
This report introduces the Nile rat as a novel model of
Metabolic Syndrome associated with diet-induced diabe-
tes in a readily managed lab rodent of intermediate size.
The diabetes was age, sex, and diet dependent, and
appeared related to stressful gene-environment interac-
tions that affected energy utilization. It is unique in its
high percentage of involvement (close to 100% in males,
somewhat less in females), and in the fact that several
aspects of the disease examined in this report (early
abdominal obesity, hyperinsulinemia, elevated blood glu-
cose and triglyceride plus hypertension, as well as unpub-
lished data on depressed HDL) mimic Metabolic
Syndrome and type 2 diabetes in humans [9,12-15].
Diet and Growth considerations
Several aspects of diabetes in Nile rats are noteworthy
from a nutritional point of view, particularly the disposi-
tion of energy for growth or storage as adipose. Specifi-
cally, males fed a chow diet (Lab Diet, #5020, 3.57 kcal/g)
grew faster than females (as expected), and they devel-
oped diabetes more readily than females, presumably
Figure 5 (Expt 7). Intraperitoneal Glucose Tolerance Test for male Nile 
rats (n = 4) fed chow and two semi-purified diets, either low-fat, high-
fiber; high-fat, low-fiber; or chow (#3000) diets for 20 wks. The figure 
depicts blood glucose change over time (mean ± SEM) post glucose 
injection (2.5 g/kg BW). * Significantly different (p < 0.05)Chaabo et al. Nutrition & Metabolism 2010, 7:29
http://www.nutritionandmetabolism.com/content/7/1/29
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Table 6: Food and water intake, body and organ weights, blood glucose and plasma lipids for 20-wk old Nile rats fed chow 
#5020 ad libitum or restricted to 75% ad libitum for 18 wks (Expt 8)
Chow 5020
ad libitum Restricted to 75%
CHO:FAT:Prot %en 57:21:22 57:21:22
Diet: Kcal/g 3.75 3.75
Body weight (g)
Initial (age: 20 wks) 112 ± 20 102 ± 8
Final after 13 wks 119 ± 23 110 ± 9
Final after 18 wks 123 ± 21 112 ± 15
gain/day 0.019 ± 0.007 0.020 ± 0.024
Food intake (g/d) 17.4 ± 6.8 13.0 ± 3.0
(kcal/d) 65 ± 25 49 ± 11
Water intake (ml/d) 19.9 ± 15.0 20.7 ± 14.4
Organ weight (%BW)
Liver 4.36 ± 0.98 3.40 ± 0.36*
Kidneys 1.01 ± 0.24 0.89 ± 0.17
Cecum 1.86 ± 0.5 1.61 ± 0.28
Adipose
Perirenal 1.21 ± 0.54 0.91 ± 0.70
Epididymal 2.26 ± 1.06 2.35 ± 0.70
Inguinal 1.45 ± 0.39 1.15 ± 0.23
Omental 1.09 ± 0.16 0.88 ± 0.29
Suprascapular (brown fat) 3.01 ± 1.18 1.80 ± 0.74
Total (all above) 9.03 ± 2.21 7.10 ± 2.05
Carcass 68.5 ± 2.86 70.0 ± 3.71
Body Length 13.7 ± 0.9 13.5 ± 0.4
BMI (kg/m2)6 . 5  ±  0 . 3 6 . 2  ±  0 . 5
LMI (kg/m2)4 . 4  ±  0 . 3 4 . 3  ±  0 . 3
ipGTT at 18 wk
0 time 211 ± 152 72 ± 35*
1 hr 517 ± 172 226 ± 135*
Blood glucose (15 h fasting), mg/dL
Initial 56 ± 19 60 ± 41
After 13 wks 70 ± 21 36 ± 3*
Final after 18 wks 211 ± 152 72 ± 35*
Plasma lipids (terminal)
TC (mg/dL) 169 ± 68 115 ± 22
TG (mg/dL) 179 ± 149 56 ± 19
Values are Mean ± SD, (n = 5-6; 2-3 females and 2-4 males per group)
* Significanly different (p < 0.05)Chaabo et al. Nutrition & Metabolism 2010, 7:29
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based on sex hormone differences. Even among individ-
ual males, those that grew faster, reminiscent of human
infants with a rapid postnatal weight gain [16-19], devel-
oped diabetes sooner (early-onset groups).
One might assume that more rapid weight gain repre-
sented greater food consumption leading to adipose
accumulation and diabetes. However, only for a brief 2 wk
period in the youngest weanlings, age 5 to 7 wks (Expt 6),
could we detect early-onset diabetes linked to greater
food intake (20%) and greater adiposity (37%). Thus, lin-
ear growth was faster (body length), relative muscle mass
less (carcass % bd wt) and fat depots greater (adipose %
bd wt) for early-onset rats. But even there, greater growth
efficiency (33% better) had a greater impact than the
increased calorie intake. In a second experiment where
food intake was tracked for 32 wks beginning at 8 wks of
age (Expt 3), calories consumed did not differ as a func-
tion of diabetes onset, but better growth efficiency (100%)
still pertained for the early-onset group. Expt 3 also
teaches that growth efficiency, as a causal link for diabe-
tes onset, only applied during rapid growth, as the rela-
tionship between calorie intake and body weight gain
disappears once growth ceases. When growth is complete
and diabetes established, calorie intake and efficiency
measures of energy utilization for growth would no lon-
ger pertain.
In late stages of the disease in older rats (T able 2, 11
mo), blood glucose and plasma lipids were severely ele-
vated, and the rats developed insulin-dependent diabetes
with adipose wasting, especially in the perirenal fat pad,
even as calorie intake doubled. This combination of wast-
ing adipose plus elevated plasma triglycerides in advanc-
ing diabetes, mimics the defect of free fatty acid recycling
seen in hyperinsulinemic humans with insulin resistance
and diabetes [9], confirming the comparable metabolic
profile in these Nile rats.
Thus, rats that used calories more efficiently to (atypi-
c a l l y )  a c c e l e r a t e  l i n e a r  g r o w t h  a n d  e a r l y  w e i g h t  g a i n ,
including adipose accumulation relative to muscle mass,
were more prone to insulin resistance and diabetes later
on. In addition, a shift to fat catabolism (especially perire-
nal fat) in the later stages of diabetes may have compli-
cated our estimates of adiposity in cross-sectional
studies, since adipose tissue may increase initially then
begin to decline, depending on the rat age and stage of
diabetes. It is important to note that, in general, the dia-
betes did not appear to depend on hyperphagia or gener-
alized obesity per se, as total body fat never exceeded 10
to 15% of body weight and, in most experiments, did not
correlate with blood glucose. This differs substantially
from most other mouse or rat models of diabetes.
Wild Nile rats
The relationship between rapid growth and diabetes is
supported by the observation that Nile rats in the wild,
where food and calories are less available, grow less rap-
idly than captive rats and do not develop diabetes. In fact,
body weight of wild Nile rats, even in the rainy season
when food is more abundant, was about 35% less in males
(ie. 85 g final wt) and 40% less in females (65 g final wt)
than comparable weights of captive-fed rats [20]. During
the dry season both male and female wild rats weighed
about 60% less than captive-fed rats. Nonetheless, wild
rats reach their reduced adult weight in approximately
the same amount of time (5 mo) as captive rats. These
differences also reflect the fact that their grasses-and-
insects diet in the wild has a caloric density close to 2.0
kcal/g [1], compared to the 3.2-4.5 kcal/g in our lab diets.
Thus, if food is curtailed by natural environmental condi-
tions linked to the dry season [20] or by food restriction
in the laboratory setting, diabetes risk is reduced.
To this point, two of the present experiments demon-
strate that dietary factors influenced the onset and degree
of diabetes observed, similar to the situation for type 2
diabetes in humans [21] and sand rats [3,5,22,23]. On the
one hand, reducing calorie intake to 75% ad libitum
affected weight gain only slightly (n.s.), but limited diabe-
tes, protecting against fatal disease much as modest
weight loss does in humans with type 2 diabetes [24].
Sand rats reportedly even reverse their diabetes if food
intake is restricted 50% before beta-cell failure occurs
[3,25]. In the second instance a high-energy, Western-
type diet (4.5 kcal/g), which would potentiate fatty acid
oxidation and fat storage, significantly elevated blood glu-
cose and rendered Nile rats severely glucose-intolerant
relative to a low-fat, high-fiber Mediterrean-type diet (3.5
kcal/g). Interestingly, despite these differences in dietary
energy density and composition, rats compensated with
the result that their total energy intake and body fat pools
did not differ for the 24 wk comparison. Furthermore,
even though the random blood glucose at study end was
highest for the low-fat (high-CHO) group, that group also
had the lowest fasting  glucose (Table 5). This suggests
that the low-fat diet still allowed for reserve insulin secre-
tion to reduce an elevated random glucose during the 16
h fast. Thus, the rate and composition of energy pro-
cessed by the Nile rat influences type 2 diabetes onset
without necessarily revealing outward signs on body
weight and adiposity. From these observations it is not
surprising that food restriction and weight loss are the
first method of choice for alleviating diabetes in humans
afflicted with type 2 diabetes [24].
"Thrifty genes" and insulin resistance
The response to restricted calorie intake and enhanced
calorie utilization for growth in Nile rats with early-onset
diabetes is also reminiscent of the sand rat, where evi-
dence for the "thrifty genes" theory was presented to
explain the prevalence of diabetes in a susceptible strain,Chaabo et al. Nutrition & Metabolism 2010, 7:29
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compared to a more resistant one [3,12,26,27]. In that sit-
uation diabetes-prone sand rats experienced 33% greater
feed efficiency and became insulin resistant, eventually
storing more energy as body fat per calorie consumed
than the resistant strain. Unfortunately, no data were pre-
sented for carcass or muscle mass representing somatic
growth rate. In the same manner, both older and younger
cohorts of Nile rats with early-onset diabetes (Expts 3 and
6) were more energy efficient than the late-onset groups
of the same age; and those in Expt 6 also accumulated
more fat early, indicating that the early-onset group (and
presumably expression of their Metabolic Syndrome) was
related to genetic control of energy utilization, particu-
larly in young rats.
These data suggest that genetically controlled growth
rate is modulated by diet composition, including dietary
calorie density [3] and availability, possibly including the
specific macronutrient composition of the diet itself. For
example, high-fat, low-fiber diets are notorious for induc-
ing diabetes in susceptible models [22]. Once growth
ceased and energy shifted from linear skeletal growth and
muscle expansion to maintenance/storage, it would
appear that insulin resistance (initiated during rapid
growth) led to sustained hyperglycemia [28]. Our late-
onset rats simply grew slower, so they delayed their des-
tiny with diabetes because they required more calories
for less growth (less efficient) early on, presumably reduc-
ing calories available for storage. In sand rats, which are
Table 7: Blood glucose and blood pressure dynamics for 13 male Nile rats fed chow (#5020) divided at 22 wks into early-
onset and late-onset groups followed for 21 wks (Expt 9)
Groups
Early-onset Late-onset
Fasting blood glucose (mg/dL)
22 wk of age 271 ± 34 77 ± 34*
27 wk of age 406 ± 73 137 ± 92*
34 wk of age 371 ± 124 71 ± 20*
40 wk of age 339 ± 43 211 ± 120*
43 wk of age 425 ± 33 288 ± 196*
Systolic blood pressure (mmHg)
27 wk of age 128 ± 8 123 ± 10
34 wk of age 156 ± 8 134 ± 6*
40 wk of age 171 ± 13 137 ± 7*
43 wk of age 164 ± 6 158 ± 7
Body weight (g)
Initial (age: 8 wks) 83 ± 5 76 ± 4
22 wk of age 115 ± 13 117 ± 12
27 wk of age 116 ± 12 125 ± 10
34 wk of age 113 ± 18 127 ± 11
40 wk of age 114 ± 14 125 ± 10
43 wk of age 109 ± 12 123 ± 11
Plasma (43 wk of age)
Insulin (ng/mL) 0.9 ± 0.9 3.0 ± 2.0*
TC (mg/dL) 413 ± 302 139 ± 98*
TG (mg/dL) 1472 ± 1282 253 ± 245*
Values are mean ± SD (early-onset n = 3, late-onset n = 10)
* Significantly different (P < 0.05)Chaabo et al. Nutrition & Metabolism 2010, 7:29
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ecologically and physiologically similar to Nile rats
[4,23,25], insulin resistance precedes hyperglycemia, sim-
ilar to humans and Nile rats [29]. One current theory sug-
gests that excessive fatty acid oxidation in muscle
mitochondria leads to ROS-induced damage that initiates
insulin resistance as a means to protect muscle from the
burden of additional energy disposal [29,30]. Another
theory suggests that excessive uptake of free fatty acids by
tissues, including inflammation and death of pancreatic
beta-cells, leads to insulin resistance and fat accumula-
tion in liver and muscle [31]. To date the role of inflam-
mation has not been explored as a factor contributing to
the Metabolic Syndrome of Nile rats.
Similar to early "growth stress" in Nile rats, epidemio-
logical studies have noted that small-for-term infants
growing faster at 7 years of age than infants with normal
birth weight were more likely to develop type 2 diabetes
as adults [32]. It is thought that in utero nutrition is a key
dynamic [33,34], but nothing is known about the specifics
of the nutrients involved or the character of postnatal
nutrition, other than high energy intake being a risk fac-
tor affecting the incidence and onset of their diabetes
[35]. It will be important to define the maternal metabo-
lism and nutrient intake of the Nile rat during pregnancy,
as well as details relative to postnatal diet composition
and behaviors around food intake that impact the growth
rate of their pups, particularly males.
In any event the Nile rat model, with a focus on growth
and food (energy) utilization during rapid growth
between 3-10 wks of age, provides an opportunity to
identify diet-gene interactions underlying insulin resis-
tance and diabetes. With this paradigm, it should be pos-
sible to intervene with diet or drug to establish relative
efficacies for prevention of overt, diet-induced insulin
resistance and diabetes in experiments of 4-7 weeks,
which is unique among animal models fully expressing
this disease from natural causes.
Model comparisons
Animal models are useful for studying the pathophysiol-
ogy of human disease and allow for therapeutic interven-
tion with an abbreviated time span relative to human
experiments. The model should mimic the human dis-
ease, or at least present its major symptoms for study. So
far no animal model mirrors all characteristics of the
Metabolic Syndrome and non-insulin-dependent (type 2)
diabetes mellitus [36]. Many mouse and rat models have
idiosyncratic similarities to certain aspects of the human
condition, often attributed to a specific gene mutation.
For example, the ob/ob [obese], db/db [diabetes] and the
Zucker diabetic fatty rat (ZDF) have mutations either in
the leptin gene (ob/ob) or in the leptin receptor (db/db)
which causes over-eating obesity, unlike the natural his-
tory of the disease in humans where leptin is seldom
implicated [37,38]. Gene analysis through backcross
breeding of diabetes-resistant and diabetes-prone sand
rats suggests that a single major gene may control the
transition from normo- to hyperglycaemia in that model
[39]. Still another sand rat report labeled larger male rats
as "obese" (with <6% of total body weight as fat), and sug-
gested their "obesity" was the reason for their insulin
resistance and diabetes. However, differential growth
measures distinguishing between lean body growth (lean
mass  per se) and BMI (adiposity) were lacking, so the
question remains whether these desert rodents develop
diabetes due to accelerated growth rates or overabundant
fat accumulation, or both [6]. The C57BL/6 mouse is
more susceptible to diet-induced obesity (DIO) and dia-
betes than other mouse strains [40], but its diabetes is not
as progressive or severe as that in either the Nile rat or
sand rat, and does not present all sequelae present in the
human disease. This is true even though the DIO mice
often double their weight from added adipose. Plus, clini-
cal aspects of diabetes in DIO mice are subtle and of min-
imal clinical consequence, taking 6-12 mo to develop.
Extreme overall obesity is not characteristic of diabetes in
Nile rats or sand rats, evidenced by the 10 to 15% upper
limit in body fat observed herein, and the 2-6% range in
male or female sand rats [6].
The utility of the Nile rat model should be emphasized
from several aspects. First, it appears to be a polygenic
wild-type rodent (outbred) that expresses all aspects of
the Metabolic Syndrome measured to date, including
abdominal fat accumulation (at least in young rats),
hyperinsulinemia, hyperglycemia, hypertriglyceridemia
(with depressed HDL, unpublished data), microalbumin-
uria (data not shown), and hypertension on the way to
terminal type 2 diabetes. Second, as in the sand rat [6],
the diabetes has 5 clearly marked stages leading to ketosis
and death, which are analogous to human type 2 diabetes.
Pathology of the liver, kidney, and pancreatic beta cells
appear to be similar to human disease [41] and invite
investigation of issues still outstanding around type 2 dia-
betes in humans, eg. mechanisms and interventions to
improve insulin secretion or kidney function associated
with normal progression of the diet-induced disease.
Third, the incidence of diabetes is high in this captive-
bred model, slightly greater than that reported for out-
bred sand rats [6]. Incidence in the sand rat has been
enhanced further by selective inbreeding in an Israeli col-
ony [3]. Almost all captive male Nile rats fed chow
become diabetic by 1 year, some as early as 6-10 wks. In
weanling sand rats diabetes developed in a susceptible
inbred strain within 2 wks on a challenge diet (only 2.9
kcal/g vs. our Nile rat challenges of 3.57 kcal/g in chow or
3.5 kcal/g and 4.5 kcal/g in our purified diets) followed by
ketosis and death in 10 wks [3]. By contrast, to date in our
older Nile rat cohorts, even our higher density diet pro-Chaabo et al. Nutrition & Metabolism 2010, 7:29
http://www.nutritionandmetabolism.com/content/7/1/29
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duced a less acute, more prolonged, but all-inclusive dis-
ease in males. Female Nile rats delay diabetes onset, with
approximately 75% eventually developing the disease by
1-1.5 yr. Similarly, severity and incidence of diabetes in
captive female sand rats was slightly less than males at 16
wk of age when fed a chow diet in an outbred colony [6].
Many data suggest that type 2 diabetes may be more com-
mon in men than women, at least premenopausal women
[32,42,43].
Certain physiological correlates of the diabetes in Nile
rats are noteworthy. First, blood glucose was highly cor-
related with hepatomegaly, which reflected hepatic ste-
a t o s i s  s i m i l a r  t o  h u m a n s  w i t h  t y p e  2  d i a b e t e s  [ 4 4 ] .
Second, kidney enlargement with polyuria, and eventual
renal failure ending in glomerular and interstitial nephri-
tis and sclerosis with reduced kidney size were associated
with polydypsia, polyuria, and ketosis at the endstage of
the disease linked to elevated glucose (unpublished data).
Diabetes progression also was associated with elevated
blood pressure, which is a frequent morbid association in
humans with diabetes [45,46]. These observations, cou-
pled with the hyperlipemia that develops as glucose rises,
suggests that abnormal energy metabolism based on liver
handling of insulin and calories leading to insulin resis-
tance are critical aspects of the disease in Nile rats, even
as they are in humans with the type 2 diabetes and Meta-
bolic Syndrome [47].
Random versus fasting glucose
One practical issue examined was whether random  or
fasting  glucose is the better measure of this diabetes.
While both measures demonstrate disease progress, the
random value is easier to execute, as it does not require
prolonged fasting. Because Nile rats are diurnal, they eat
predominantly during the day, so a random glucose value
is never far removed from eating, which can be consid-
ered a continuous stimulus for insulin secretion during
daytime [2]. Furthermore, first signs of glucose intoler-
ance (insulin resistance) can be detected easier with
excursions in random blood glucose than with fasting
glucose. A 16 h fasting glucose value, on the other hand,
provides the opportunity to determine whether enough
insulin can still be generated to clear circulating glucose,
thereby demonstrating the reserve capacity of beta-cell
function in the host. When insulin secretion is waning in
Nile rats, fasting glucose remains elevated, even as it does
with fasting in advanced type 2 diabetes in humans
[14,24,48].
Thus, in this model energy (glucose, triglycerides) is
not removed from systemic circulation effectively despite
elevated insulin (hyperinsulinemia reflecting insulin
resistance), which leads to a blood glucose increase that
eventually leads to beta-cell failure with decreased insulin
production [47,49,50]. The cutoff points for blood glu-
cose differ for fasting or random glucose, but they were
highly related. Random glucose above 150 mg/dl was a
good predictor of diabetes from the current data, while
fasting glucose >110 mg/dl seems reasonable for diabetes
onset. Random glucose commonly rises to 300-500 mg/
dl, often over 600 mg/dl, in Nile rats with advanced dia-
betes and insulin depletion, whereas fasting glucose sel-
dom exceeds 400 mg/dl, even in the worst case of
diabetes. Slower progressing diabetes in older Nile rats
also was associated with a much greater hyperglycemia
and hyperlipemia, with elevated VLDL-TG (up to10-
fold), total cholesterol (5-fold) and HDL depressed to 1/5
normal (unpublished data). By contrast, triglycerides and
cholesterol reportedly rise only minimally in sand rats
[51].
Conclusion
The data presented indicate that the African grass rat
(Nile rat) represents a novel model of Metabolic Syn-
drome associated with diet-induced type 2 diabetes,
expressing developmental growth and nutritional corre-
lates similar to those in humans. All aspects of the Meta-
bolic Syndrome and the Insulin Resistance Syndrome
examined to date in captive Nile rats appear to mimic
those of type 2 diabetes in humans [9,14,48,52]. Like
humans, males appear more susceptible than females,
with insulin resistance and diabetes developing within 4
wks of adverse nutritional circumstances. Generalized
obesity to initiate diabetes is not a prerequisite, although
the most metabolically active fat pool (abdominal fat)
appears linked to disease onset and terminal energy
dynamics during ketosis. The apparent dysfunction in
hepatic energy metabolism adds to the comparative
appeal of this model. As such, it represents an excellent
opportunity for study of nutritional aspects of type 2 dia-
betes, ie. from diet compostion impacting insulin resis-
tance, to liver and kidney failure and death.
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